Pulse Biosciences, Inc. (PLSE) — Insider Activity & Signal

Healthcare · Medical - Instruments & Supplies · Market cap $2.9B · $42.41 · 52-week range $12.56–$45.90

Recent insider buying

Open-market purchases reported to the SEC (last six months). Option grants and tax-withholding sales are excluded.

Date	Insider	Role	Shares	Price	Value	Source
2026-05-11	DUGGAN ROBERT W	director, 10 percent owner:	660,233	$19.69	$12,999,988	SEC Form 4
2026-05-11	LAVIOLETTE PAUL A	director, officer: Chief Executive Officer	15,000	$19.69	$295,350	SEC Form 4
2026-05-11	LAVIOLETTE PAUL A	director, officer: Chief Executive Officer	15,000	$19.69	$295,350	SEC Form 4
2026-05-11	DUGGAN ROBERT W	director, 10 percent owner:	660,233	$19.69	$12,999,988	SEC Form 4

Financial health

Altman Z-Score 91.41 · Piotroski F-Score 3/9 · Cash $81M · Debt $8M

ClearOcean signal read

ClearOcean's model is monitoring this name but has not flagged a qualifying signal at this time.

Sources & further reading

Primary filings: SEC EDGAR — PLSE Form 4
How ClearOcean reads insider activity

Last updated August 08, 2026.

ClearOcean is a software research tool, not an investment adviser or broker-dealer. This page aggregates public data (incl. SEC filings) for informational purposes only — it is not investment advice, nor a recommendation, offer or solicitation to buy or sell any security. Past activity does not predict future results. You are solely responsible for your decisions; investing can lose value, up to total loss of capital.